Oppenheimer Maintains Outperform on Xylem, Lowers Price Target to $135
Benzinga Newsdesk 2 days ago
Analyst RatingsNewsPrice Target
Oppenheimer analyst Bryan Blair maintains Xylem (NYSE:XYL) with a Outperform and lowers the price target from $150 to $135.
Oppenheimer analyst Bryan Blair maintains Xylem (NYSE:XYL) with a Outperform and lowers the price target from $150 to $135.